Sorbus Pharmaceuticals GmbH incorporated in Vienna, Austria
09-Feb-2010 -
Sorbus Pharmaceuticals GmbH announced its incorporation in Vienna, Austria. Sorbus discovers and develops novel treatments for complicated wounds, cancer and other life-threatening diseases. Its lead drug, SertaSil, has demonstrated exceptional effects in patients with acute and chronic wounds ...
bacteria
chronic wounds
diabetic foot ulcers
+2